推荐产品
等级
certified reference material
质量水平
形式
liquid
特点
Snap-N-Spike®/Snap-N-Shoot®
包装
ampule of 1 mL
制造商/商品名称
Cerilliant®
drug control
psicótropo (Spain); Decreto Lei 15/93: Tabela IIB (Portugal)
浓度
1.0 mg/mL in methanol
技术
gas chromatography (GC): suitable
liquid chromatography (LC): suitable
应用
cannabis testing
forensics and toxicology
格式
single component solution
储存温度
2-8°C
SMILES字符串
OC1=CC(CCCCC)=CC2=C1C3C=C(CO)CCC3C(O2)(C)C
InChI
1S/C21H30O3/c1-4-5-6-7-14-11-18(23)20-16-10-15(13-22)8-9-17(16)21(2,3)24-19(20)12-14/h10-12,16-17,22-23H,4-9,13H2,1-3H3
InChI key
YCBKSSAWEUDACY-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
一般描述
经认证的加标溶液®，适用于LC/MS或GC/MS应用，用于大麻素测试，尿液药物测试，临床毒理学或法医分析。11-羟基-Δ9-THC 是大麻主要精神活性成分（Δ9--四氢大麻酚 (Δ9-THC)）的主要氧化代谢物。
应用
该认证加标溶液®适用于通过 HPLC、GC/MS 或 LC-MS/MS 法进行 (±)-11-羟基-Δ9-THC 测定，从而用于法医分析、临床毒理学、尿液药物测试和大麻效力或杂质分析测试等应用。该认证标准物质（CRM）还可作如下用途：
- 使用超高效液相色谱（UHPLC）结合三重四极杆质谱法在液-液萃取后定量测定人血浆样品中的大麻二酚和 Δ9-四氢大麻酚，以及鉴定少量大麻素
- 基于液相色谱-串联质谱（LC-MS/MS）法在固相萃取（SPE）后测定口服液样品中的 10 种大麻素
- 通过气相色谱（GC）联合三重四极杆质谱仪分析血浆和尿液中 Δ9-四氢大麻酚（Δ9-THC）及其三种代谢物
- 开发基于固相萃取（SPE）的自动样品制备方法，以使用液相色谱-质谱法（LC-MS）测定血清、唾液和尿液中 ∆9--四氢大麻酚（THC）及其三种主要代谢物
- 通过大气压化学电离气相色谱-串联质谱法（APGC-MS/MS）同时测定人血清样品中的大麻素及其代谢物
特点和优势
- 完全符合 ISO/IEC 17025 和 ISO 17034 认证
- 附综合分析证书（CoA），包括稳定性、均匀性、浓度准确性、不确定性和可追溯性数据
- 通过实时稳定性研究严格测试，以确保准确性和保质期
- 使用合格的精密天平进行重量准备，以确保最小不确定性
- 氩气环境下火焰密封，装入安瓿以便长期保存
- 提供方便的 DEA 豁免格式，以提高实验室效率
法律信息
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
警示用语：
Danger
危险分类
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
靶器官
Eyes
WGK
WGK 1
闪点(°F)
closed cup
闪点(°C)
closed cup
法规信息
监管及禁止进口产品
J Röhrich et al.
Journal of analytical toxicology, 34(4), 196-203 (2010-05-15)
Cannabinoid concentrations in blood and urine after passive exposure to cannabis smoke under real-life conditions were investigated in this study. Eight healthy volunteers were exposed to cannabis smoke for 3 h in a well-attended coffee shop in Maastricht, Netherlands. An
Ross H Lowe et al.
Drug and alcohol dependence, 105(1-2), 24-32 (2009-07-28)
Generally, urinary 11-nor-9-carboxy-Delta9-tetrahydrocannabinol (THCCOOH) after alkaline hydrolysis is monitored to detect cannabis exposure, although last use may have been weeks prior in chronic cannabis users. Delta9-Tetrahydrocannabinol (THC) and 11-hydroxy-THC (11-OH-THC) concentrations in urine following Escherichia coli beta-glucuronidase hydrolysis were proposed
Erin L Karschner et al.
Journal of analytical toxicology, 33(8), 469-477 (2009-10-31)
Delta(9)-Tetrahydrocannabinol (THC) is commonly found in toxicological specimens from driving under the influence and accident investigations. Plasma cannabinoid concentrations were determined in 18 long-term heavy cannabis smokers residing on an in-patient research unit for seven days of monitored abstinence. THC
Stefan W Toennes et al.
Archiv fur Kriminologie, 225(3-4), 90-98 (2010-05-29)
When defendants are confronted with evidence of cannabinoids in their blood suggesting consumption of cannabis they sometimes argue that this could only be due to a passive exposure. The small number of controlled studies available showed that tetrahydrocannabinol (THC), the
Cynthia Coulter et al.
Journal of analytical toxicology, 32(8), 653-658 (2008-11-15)
An analytical procedure for the determination of Delta9-tetrahydrocannabinol (THC), 11-nor-9-carboxy-Delta9-tetrahydrocannabinol (THCA), and 11-hydroxy-Delta9-tetrahydrocannabinol (11-OH-THC) in whole blood has been developed and validated using liquid chromatography with tandem mass spectral detection (MS). Cannabinoids present in the blood samples were quantified using
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门